Vivo Opportunity Fund Holdings, L.P. → Achieve Life Sciences, Inc. ACHV

Stake: — Shares: — Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 10.88

17,474,108 shares short · +9.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $374K

Point72 Asset Mgmt

Other 13D/G Filings on Achieve Life Sciences, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-17	SCHEDULE 13G	Logos Global Management LP	—	—	view →
2026-08-13	SCHEDULE 13G	Janus Henderson Group Ltd.	—	—	view →
2026-07-27	SCHEDULE 13G	BlackRock, Inc.	—	—	view →
2026-04-27	SCHEDULE 13D	venBio Global Strategic Fund V, L.P.	9.99%	10,737,317	view →
2026-04-24	SCHEDULE 13D	TPG GP A, LLC	12.60%	13,755,160	view →
2023-03-23	SC	DIALECTIC CAPITAL MANAGEMENT, LP	—	—	view →

Other Filings by Vivo Opportunity Fund Holdings, L.P.

Filed	Form	Issuer	Stake	Shares
2026-10-13	SCHEDULE 13G	ArriVent BioPharma, Inc.	—	—	view →
2026-06-10	SCHEDULE 13D	InMed Pharmaceuticals Inc. INM	21.70%	718,444	view →
2023-10-11	SC	SOLENO THERAPEUTICS INC SLNO	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →